{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:49:43Z","timestamp":1794620983064,"version":"4.9.1"},"reference-count":138,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010097","name":"China Association for Science and Technology","doi-asserted-by":"publisher","award":["CACM-2020-QNRC1\u201301"],"award-info":[{"award-number":["CACM-2020-QNRC1\u201301"]}],"id":[{"id":"10.13039\/100010097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003879"],"award-info":[{"award-number":["82003879"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U19A2010"],"award-info":[{"award-number":["U19A2010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"publisher","award":["2021KJT0009"],"award-info":[{"award-number":["2021KJT0009"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005891","name":"State Administration of Traditional Chinese Medicine of the People's Republic of China","doi-asserted-by":"publisher","award":["ZYYCXTD-D-202209"],"award-info":[{"award-number":["ZYYCXTD-D-202209"]}],"id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.biopha.2023.114522","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:45:38Z","timestamp":1678754738000},"page":"114522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Update on the sources, pharmacokinetics, pharmacological action, and clinical application of anisodamine"],"prefix":"10.1016","volume":"161","author":[{"given":"Yuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0289-4426","authenticated-orcid":false,"given":"Fu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.114522_bib1","first-page":"7","article-title":"Total synthesis of anisodamine .","author":"Xie","year":"1980","journal-title":"Chin. J. Pharm."},{"issue":"03","key":"10.1016\/j.biopha.2023.114522_bib2","doi-asserted-by":"crossref","first-page":"7500032","DOI":"10.1142\/S0192415X75000323","article-title":"Anisodamine in treatment of some diseases with manifestations of acute microcirculatory insufficiency .","volume":"03","author":"Journal","year":"1975","journal-title":"Chin. Med J."},{"issue":"6","key":"10.1016\/j.biopha.2023.114522_bib3","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/j.1365-2125.2011.03936.x","article-title":"Pharmacokinetic-pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects .","volume":"71","author":"Liem-Moolenaar","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2023.114522_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/jat.1154","article-title":"The pharmacological properties of anisodamine .","volume":"27","author":"Poupko","year":"2007","journal-title":"J. Appl. Toxicol.: JAT"},{"issue":"3","key":"10.1016\/j.biopha.2023.114522_bib5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0300-9572(83)90005-9","article-title":"Experimental study in rabbits of the antishock effect of anisodamine (654-2), and its mechanism of action .","volume":"10","author":"Su","year":"1983","journal-title":"Resuscitation"},{"issue":"12","key":"10.1016\/j.biopha.2023.114522_bib6","first-page":"976","article-title":"Cell protection mechanism of antishock action of anisodamine .","volume":"105","author":"Su","year":"1992","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.biopha.2023.114522_bib7","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.1982.03320350062033","article-title":"Anisodamine inhibits thromboxane synthesis, granulocyte aggregation, and platelet aggregation .","volume":"247","author":"Xue","year":"1982","journal-title":"JAMA"},{"issue":"08","key":"10.1016\/j.biopha.2023.114522_bib8","first-page":"666","article-title":"Anisodamine inhibits acetylcholine-induced endothelium-dependent relaxation of canine femoral artery .","volume":"105","author":"Guo","year":"1992","journal-title":"Chin. Med. J."},{"issue":"2","key":"10.1016\/j.biopha.2023.114522_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0378-8741(90)90001-A","article-title":"Anisodamine increases blood flow to the retina-choroid and protects retinal and pancreatic cells against lipid peroxidation .","volume":"30","author":"Shu-Lun","year":"1990","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2023.114522_bib10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1021\/acssynbio.9b00461","article-title":"Engineering tropane alkaloid production based on metabolic characterization of ornithine decarboxylase in Atropa belladonna .","volume":"9","author":"Zhao","year":"2020","journal-title":"ACS Synth. Biol."},{"issue":"19","key":"10.1016\/j.biopha.2023.114522_bib11","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.phytochem.2007.05.025","article-title":"Antisense-mediated reduction in ADC activity causes minor alterations in the alkaloid profile of cultured hairy roots and regenerated transgenic plants of Nicotiana tabacum .","volume":"68","author":"Chintapakorn","year":"2007","journal-title":"Phytochemistry"},{"issue":"4\u20135","key":"10.1016\/j.biopha.2023.114522_bib12","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.phytochem.2010.12.012","article-title":"RNAi-mediated down-regulation of ornithine decarboxylase (ODC) leads to reduced nicotine and increased anatabine levels in transgenic Nicotiana tabacum L .","volume":"72","author":"Deboer","year":"2011","journal-title":"Phytochemistry"},{"key":"10.1016\/j.biopha.2023.114522_bib13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF00197787","article-title":"Studies on the biosynthesis of tropane alkaloids in Datura stramonium L. transformed root cultures: 1. The kinetics of alkaloid production and the influence of feeding intermediate metabolites .","author":"Robins","year":"1991","journal-title":"Planta"},{"issue":"15\u201316","key":"10.1016\/j.biopha.2023.114522_bib14","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.phytochem.2009.06.012","article-title":"Putrescine N-methyltransferase\u2013the start for alkaloids .","volume":"70","author":"Biastoff","year":"2009","journal-title":"Phytochemistry"},{"issue":"8","key":"10.1016\/j.biopha.2023.114522_bib15","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.3390\/molecules13081722","article-title":"Application of metabolic engineering to the production of scopolamine .","volume":"13","author":"Palaz\u00f3n","year":"2008","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.biopha.2023.114522_bib16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.chembiol.2006.03.005","article-title":"Functional genomic analysis of alkaloid biosynthesis in Hyoscyamus niger reveals a cytochrome P450 involved in littorine rearrangement .","volume":"13","author":"Li","year":"2006","journal-title":"Chem. Biol."},{"issue":"9","key":"10.1016\/j.biopha.2023.114522_bib17","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock .","volume":"369","author":"Angus","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biopha.2023.114522_bib18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s13054-021-03774-4","article-title":"Effectiveness of anisodamine for the treatment of critically ill patients with septic shock: a multicentre randomized controlled trial .","volume":"25","author":"Yu","year":"2021","journal-title":"Crit. care (Lond., Engl. )"},{"issue":"9","key":"10.1016\/j.biopha.2023.114522_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107181","article-title":"Epidemiology and outcome of severe sepsis and septic shock in intensive care units in mainland China .","volume":"9","author":"Zhou","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2023.114522_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fphar.2011.00023","article-title":"Beneficial effects of anisodamine in shock involved cholinergic anti-inflammatory pathway .","volume":"2","author":"Zhao","year":"2011","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.biopha.2023.114522_bib21","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.1982.03320350062033","article-title":"Anisodamine inhibits thromboxane synthesis, granulocyte aggregation, and platelet aggregation. A possible mechanism for its efficacy in bacteremic shock .","volume":"247","author":"Xiu","year":"1982","journal-title":"Jama"},{"issue":"6","key":"10.1016\/j.biopha.2023.114522_bib22","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/aps.2012.26","article-title":"Combined administration of anisodamine and neostigmine produces anti-shock effects: involvement of \u03b17 nicotinic acetylcholine receptors .","volume":"33","author":"Sun","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2023.114522_bib23","unstructured":"Ri-Xing W., Ming-Qiang L., Jia-Cong L., et al. Effects and safety of different anisodamine doses on EVLW at early stage of septic shock patients .. Journal of Hainan Medical University, 2017."},{"issue":"1","key":"10.1016\/j.biopha.2023.114522_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-021-03854-5","article-title":"Anisodamine microcirulatory effects in septic shock: be aware of cardiac side effects .","volume":"25","author":"Honore","year":"2021","journal-title":"Crit. Care"},{"issue":"9","key":"10.1016\/j.biopha.2023.114522_bib25","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock .","volume":"362","author":"De Backer","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biopha.2023.114522_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-021-03774-4","article-title":"Effectiveness of anisodamine for the treatment of critically ill patients with septic shock: a multicentre randomized controlled trial .","volume":"25","author":"Yu","year":"2021","journal-title":"Crit. Care"},{"issue":"11\u201312","key":"10.1016\/j.biopha.2023.114522_bib27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.lfs.2011.07.008","article-title":"The antishock effect of anisodamine requires the upregulation of alpha7 nicotine acetylcholine receptors by IL-10 .","volume":"89","author":"Li","year":"2011","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.biopha.2023.114522_bib28","article-title":"Protection of anisodamine on the remote organ injury after hepatic ischemia reperfusion in rats .","volume":"5","author":"Zhu","year":"2010","journal-title":"J. Chin. Clin. Med."},{"issue":"1609","key":"10.1016\/j.biopha.2023.114522_bib29","article-title":"Anisodamine suppressed the growth of hepatocellular carcinoma cells, induced apoptosis and regulated the levels of inflammatory factors by inhibiting NLRP3 inflammasome activation .","volume":"14","author":"Li","year":"2020","journal-title":"Drug Des., Dev. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2023.114522_bib30","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1440-1746.2008.05756.x","volume":"24","author":"Luo","year":"2009","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2023.114522_bib31","doi-asserted-by":"crossref","unstructured":"Li C.-H., Zhang X., Ge X.-L., et al., Effects of combined anisodamine and neostigmine treatment on the inflammatory response and liver regeneration of obstructive jaundice rats after hepatectomy .. BioMed Research International, 2014, 2014.","DOI":"10.1155\/2014\/362024"},{"issue":"39","key":"10.1016\/j.biopha.2023.114522_bib32","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.3748\/wjg.v19.i39.6618","article-title":"Anisodamine accelerates spontaneous passage of single symptomatic bile duct stones\u2264 10 mm .","volume":"19","author":"Gao","year":"2013","journal-title":"World J. Gastroenterol.: WJG"},{"key":"10.1016\/j.biopha.2023.114522_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.700050","article-title":"Therapeutic Effect of Combining Anisodamine With Neostigmine on Local Scar Formation Following Roux-en-Y Choledochojejunostomy in a Novel Rat Model .","volume":"12","author":"Lyu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2023.114522_bib34","first-page":"28","article-title":"Effect of compatibility of pethidine hydrochloride and anisodamine on the patients with advanced malignant obstructive jaundice in PTBS operation .","volume":"611\u20133","author":"Li","year":"2017","journal-title":"J. Pract. Radiol."},{"key":"10.1016\/j.biopha.2023.114522_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174095","article-title":"Cardioprotective effect of anisodamine against ischemia\/reperfusion injury through the mitochondrial ATP-sensitive potassium channel .","volume":"901","author":"Bai","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"Suppl 3","key":"10.1016\/j.biopha.2023.114522_bib36","first-page":"A199-A","article-title":"e0645 Protective effects of simvastatin combined with anisodamine on myocardial perfusion in swine no reflow model .","volume":"96","author":"Xianghua","year":"2010","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.biopha.2023.114522_bib37","first-page":"1253","article-title":"Cardioprotective effects of anisodamine against myocardial ischemia\/reperfusion injury through the inhibition of oxidative stress, inflammation and apoptosis .","volume":"17","author":"Yao","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2023.114522_bib38","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/MCA.0000000000000366","article-title":"Intracoronary administration of different doses of anisodamine in primary percutaneous coronary intervention: protective effect in patients with ST-segment elevation myocardial infarction .","volume":"27","author":"Bai","year":"2016","journal-title":"Coron. Artery Dis."},{"issue":"S1","key":"10.1016\/j.biopha.2023.114522_bib39","first-page":"839","article-title":"Comparison of myocardial microcirculatory perfusion after catheter\u2010administered intracoronary thrombolysis with anisodamine versus standard thrombus aspiration in patients with ST\u2010elevation myocardial infarction .","volume":"93","author":"Fu","year":"2019","journal-title":"Catheter. Cardiovasc. Interv."},{"issue":"8","key":"10.1016\/j.biopha.2023.114522_bib40","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/MCA.0000000000000167","article-title":"Effect of intracoronary anisodamine and diltiazem administration during primary percutaneous coronary intervention in acute myocardial infarction .","volume":"25","author":"Peng","year":"2014","journal-title":"Coron. Artery Dis."},{"issue":"Suppl 2","key":"10.1016\/j.biopha.2023.114522_bib41","doi-asserted-by":"crossref","first-page":"E203-E","DOI":"10.1136\/heartjnl-2012-302920l.10","article-title":"MYOCARDIAL PROTECTIVE EFFECTS OF ANISODAMINE IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION UNDERGOING EARLY PERCUTANEOUS CORONARY INTERVENTION FOLLOWING THROMBOLYSIS .","volume":"98","author":"Xianghua","year":"2012","journal-title":"Heart"},{"issue":"Suppl 3","key":"10.1016\/j.biopha.2023.114522_bib42","doi-asserted-by":"crossref","first-page":"A148-A","DOI":"10.1136\/heartjnl-2011-300867.433","article-title":"Preventive effects of intracoronary administration of Anisodamine on myocardial microcirculation perfusion after primary PCI in STEMI patients .","volume":"97","author":"Xianghua","year":"2011","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.biopha.2023.114522_bib43","article-title":"Effect of intracoronary injection of tirofiban combined with anisodamine on myocardial perfusion in patients with STEMI after PCI .","volume":"22","author":"Zhu","year":"2016","journal-title":"J. Hainan Med. Univ."},{"issue":"Suppl 3","key":"10.1016\/j.biopha.2023.114522_bib44","first-page":"A152","article-title":"Protective effects of anisodamine on contrast induced nephropathy in patients with ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention .","volume":"97","author":"Xianghua","year":"2011","journal-title":"Heart"},{"issue":"7","key":"10.1016\/j.biopha.2023.114522_bib45","doi-asserted-by":"crossref","DOI":"10.12669\/pjms.38.7.5410","article-title":"The effects of Anisodamine-Tirofiban Combined Therapy in acute myocardial infarction treated with Percutaneous Coronary Intervention (PCI) .","volume":"38","author":"Jiao","year":"2022","journal-title":"Pak. J. Med. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2023.114522_bib46","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1385\/CT:4:4:375","article-title":"The oxygen radical generator pyrogallol impairs cardiomyocyte contractile function via a superoxide and p38 MAP kinase-dependent pathway .","volume":"4","author":"Esberg","year":"2004","journal-title":"Cardiovasc. Toxicol."},{"issue":"3","key":"10.1016\/j.biopha.2023.114522_bib47","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3892\/etm.2015.2623","article-title":"Intracoronary administration of anisodamine and nicorandil in individuals undergoing primary percutaneous coronary intervention for acute inferior myocardial infarction: a randomized factorial trial .","volume":"10","author":"Chen","year":"2015","journal-title":"Exp. Ther. Med."},{"issue":"6","key":"10.1016\/j.biopha.2023.114522_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/etm.2022.11349","article-title":"Anisodamine hydrobromide ameliorates cardiac damage after resuscitation .","volume":"23","author":"Dong","year":"2022","journal-title":"Exp. Ther. Med."},{"issue":"05","key":"10.1016\/j.biopha.2023.114522_bib49","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1142\/S0192415X11009251","article-title":"Inhibition of endoplasm reticulum stress by anisodamine protects against myocardial injury after cardiac arrest and resuscitation in rats .","volume":"39","author":"Yin","year":"2011","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.biopha.2023.114522_bib50","first-page":"211","article-title":"Effects of anisodamine on myocardial caspase-1 and interleukin-18 expression following overtraining-induced acute myocardial injury in rats .","author":"Li","year":"2012","journal-title":"Chin. J. Anesthesiol."},{"key":"10.1016\/j.biopha.2023.114522_bib51","first-page":"610","article-title":"Effects of anisodamine on apoptosis in cardiomyocytes and inflammatory response in overtrained rats .","author":"Rong","year":"2011","journal-title":"Chin. J. Anesthesiol."},{"key":"10.1016\/j.biopha.2023.114522_bib52","first-page":"204","article-title":"Application of anisodamine to remifentanil during enteroscopy without pain for patients with bradycardia .","author":"Liang","year":"2015","journal-title":"Chongqing Med."},{"issue":"09","key":"10.1016\/j.biopha.2023.114522_bib53","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3760\/cma.j.issn.0366-6999.20132713","article-title":"Intravenous administration of anisodamine is effective on variant angina .","volume":"127","author":"Hou","year":"2014","journal-title":"Chin. Med. J."},{"issue":"12","key":"10.1016\/j.biopha.2023.114522_bib54","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1097\/01.WCB.0000037880.62590.28","article-title":"Inflammation and infection in clinical stroke .","volume":"22","author":"Emsley","year":"2002","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2023.114522_bib55","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/cns.12160","article-title":"Moderate hypothermia inhibits brain inflammation and attenuates stroke\u2010induced immunodepression in rats .","volume":"20","author":"Gu","year":"2014","journal-title":"CNS Neurosci. Ther."},{"issue":"11","key":"10.1016\/j.biopha.2023.114522_bib56","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1161\/hs1101.098151","article-title":"Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study .","volume":"32","author":"Rost","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.biopha.2023.114522_bib57","first-page":"6","article-title":"Scopolamine (hyoscine) for preventing and treating motion sickness .","author":"Spinks","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.biopha.2023.114522_bib58","first-page":"2022","article-title":"Observation of Clinical Efficacy of Anisodamine and Chlorpromazine in the Treatment of Intractable Hiccup after Stroke .","author":"Wang","year":"2022","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.biopha.2023.114522_bib59","author":"Xiaocheng","year":"2012","journal-title":"Expr. Calcitonin-.-. gene-Relat. Pept. efferent Vestib. Syst. Vestib. Nucl. Rats. Motion Sick. [J. ]"},{"issue":"5","key":"10.1016\/j.biopha.2023.114522_bib60","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/ijs.12458","article-title":"A combination of neostigmine and anisodamine protects against ischemic stroke by activating \u03b17nAChR .","volume":"10","author":"Qian","year":"2015","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.biopha.2023.114522_bib61","first-page":"164","article-title":"Pain analgesic efficacy of diclofenac sodium and lidocaine hydrochloride combined with anisodamine in treatment of patients with bone fractures and evaluation of its safety .","author":"Fu","year":"2015","journal-title":"Chin. J. Biochem. Pharm."},{"issue":"07","key":"10.1016\/j.biopha.2023.114522_bib62","first-page":"636","article-title":"Anisodamine protects against neuronal death following cerebral ischemia in gerbils .","volume":"113","author":"Chen","year":"2000","journal-title":"Chin. Med. J."},{"issue":"7","key":"10.1016\/j.biopha.2023.114522_bib63","first-page":"1340","article-title":"Anisodamine Inhibits Bleomycin-induced Pulmonary Fibrosis through Inhibition against Endoplasmic Reticulum Stress .","volume":"37","author":"Li","year":"2018","journal-title":"Lat. Am. J. Pharm."},{"issue":"35","key":"10.1016\/j.biopha.2023.114522_bib64","article-title":"Anisodamine hydrobromide protects against acute lung injury in septic rats induced by lipopolysaccharide or cecal ligation and puncture via inhibiting apoptosis and pyroptosis .","author":"Zeng","year":"2021","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.biopha.2023.114522_bib65","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1124\/jpet.121.001019","article-title":"Anisodamine Enhances Macrophage M2 Polarization through Suppressing G9a-Mediated Interferon Regulatory Factor 4 Silencing to Alleviate Lipopolysaccharide-Induced Acute Lung Injury .","volume":"381","author":"Zhang","year":"2022","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"10","key":"10.1016\/j.biopha.2023.114522_bib66","doi-asserted-by":"crossref","DOI":"10.21037\/atm-21-1750","article-title":"Protective effect of anisodamine on bleomycin-induced acute lung injury in immature rats via modulating oxidative stress, inflammation, and cell apoptosis by inhibiting the JAK2\/STAT3 pathway .","volume":"9","author":"Zhao","year":"2021","journal-title":"Ann. Transl. Med."},{"issue":"2","key":"10.1016\/j.biopha.2023.114522_bib67","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s12013-012-9475-6","article-title":"Effects of high dose of anisodamine on the respiratory function of patients with traumatic acute lung injury .","volume":"66","author":"Guoshou","year":"2013","journal-title":"Cell Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.biopha.2023.114522_bib68","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.taap.2012.04.020","article-title":"Protective effects of anisodamine on cigarette smoke extract-induced airway smooth muscle cell proliferation and tracheal contractility .","volume":"262","author":"Xu","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2023.114522_bib69","first-page":"220","article-title":"Anisodamine ameliorates ischemia\/reperfusion-induced renal injury in rats through activation of the extracellular signal-regulated kinase (ERK) pathway and anti-apoptotic effect .. Die Pharmazie-An","volume":"76","author":"Zhang","year":"2021","journal-title":"Int. J. Pharm. Sci."},{"issue":"19","key":"10.1016\/j.biopha.2023.114522_bib70","first-page":"3368","article-title":"Preventive effects of anisodamine against contrast-induced nephropathy in type 2 diabetics with renal insufficiency undergoing coronary angiography or angioplasty .","volume":"125","author":"Geng","year":"2012","journal-title":"Chin. Med. J."},{"issue":"16S","key":"10.1016\/j.biopha.2023.114522_bib71","doi-asserted-by":"crossref","first-page":"C86-C","DOI":"10.1016\/j.jacc.2018.08.464","article-title":"GW29-e1322 Probucol and anisodamine prevents contrast induced nephropathy in diabetic rats by inhibiting Akt\/mTOR\/P70S6K signaling pathways .","volume":"72","author":"Zhao","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"26","key":"10.1016\/j.biopha.2023.114522_bib72","first-page":"1949","article-title":"Effects of penehyclidine hydrochloride and anisodamine on acute kidney injury induced by two-hit rats .","volume":"6","author":"Dong-Ting","year":"2012","journal-title":"Afr. J. Pharm. Pharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2023.114522_bib73","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20201812","article-title":"Protective effect of anisodamine hydrobromide on lipopolysaccharide-induced acute kidney injury .","volume":"40","author":"Wan","year":"2020","journal-title":"Biosci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2023.114522_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-019-1394-y","article-title":"Protective effect of anisodamine in rats with glycerol-induced acute kidney injury .","volume":"20","author":"Li","year":"2019","journal-title":"BMC Nephrol."},{"issue":"12","key":"10.1016\/j.biopha.2023.114522_bib75","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s10495-017-1414-y","article-title":"Anisodamine inhibits endoplasmic reticulum stress-associated TXNIP\/NLRP3 inflammasome activation in rhabdomyolysis-induced acute kidney injury .","volume":"22","author":"Yuan","year":"2017","journal-title":"Apoptosis"},{"issue":"2","key":"10.1016\/j.biopha.2023.114522_bib76","first-page":"340","article-title":"Treatment of dilated cardiomyopathy caused by coronary microvascular dysfunction with anisodamine: a report of 5 cases .","volume":"40","author":"Zhiwei","year":"2020","journal-title":"J. Tradit. Chin. Med."},{"issue":"14","key":"10.1016\/j.biopha.2023.114522_bib77","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/00029330-200707020-00004","article-title":"Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction .","volume":"120","author":"Fu","year":"2007","journal-title":"Chin. Med. J."},{"issue":"7","key":"10.1016\/j.biopha.2023.114522_bib78","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.4314\/tjpr.v20i7.15","article-title":"Evaluation of anisodamine-mediated amelioration of hypoxic injury in brain microvascular endothelial cells .","volume":"20","author":"Wang","year":"2021","journal-title":"Trop. J. Pharm. Res."},{"issue":"Suppl 3","key":"10.1016\/j.biopha.2023.114522_bib79","doi-asserted-by":"crossref","first-page":"A202-A","DOI":"10.1136\/hrt.2010.208967.654","article-title":"e0654 The effect of preventive intracoronary administration of anisodamine on microcirculation perfusion in miniswines with AMI .","volume":"96","author":"Xianghua","year":"2010","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.biopha.2023.114522_bib80","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s13239-020-00486-8","article-title":"Anisodamine hydrobromide protects glycocalyx and against the lipopolysaccharide-induced increases in microvascular endothelial layer permeability and nitric oxide production .","volume":"12","author":"Du","year":"2021","journal-title":"Cardiovasc. Eng. Technol."},{"issue":"6","key":"10.1016\/j.biopha.2023.114522_bib81","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/1708538113478756","article-title":"Combined use of heparin and anisodamine reduces the risk of early thrombosis in native arteriovenous fistula .","volume":"21","author":"Chen","year":"2013","journal-title":"Vascular"},{"issue":"1","key":"10.1016\/j.biopha.2023.114522_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117133","article-title":"Endothelial surface glycocalyx can regulate flow-induced nitric oxide production in microvessels in vivo .","volume":"10","author":"Yen","year":"2015","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.biopha.2023.114522_bib83","first-page":"3","article-title":"Effects of anisodamine on erythrocyte membrane fluidity and endogenous fluorescence .","volume":"10","author":"Yang","year":"1993","journal-title":"Mod. Appl. Pharm."},{"key":"10.1016\/j.biopha.2023.114522_bib84","first-page":"15","article-title":"The effect of anisodamine on lipoprotein metabolism in the liver and the plasma membrane phospholipids of the hepatocytes in hemorrhagic shock .","volume":"1","author":"Leskova","year":"1990","journal-title":"Patol. Fiziol. i Eksp. 'naia Ter."},{"issue":"5","key":"10.1016\/j.biopha.2023.114522_bib85","first-page":"349","article-title":"Protective effect of anisodamine on arrhythmia and lipid peroxidation during ischemia-reperfusion in anesthetized rats .","volume":"13","author":"Yao","year":"1992","journal-title":"J. Fourth Mil. Med. Univ."},{"issue":"002","key":"10.1016\/j.biopha.2023.114522_bib86","first-page":"152-152","article-title":"Effect of Anisodamine on Myocardial Ischemia-Reperfusion Injury and Anti-Lipid Peroxidation .","volume":"016","author":"Yao","year":"1995","journal-title":"Acta Pharmacol. Sin."},{"issue":"006","key":"10.1016\/j.biopha.2023.114522_bib87","first-page":"12","article-title":"Effect OF ANISOdamine on lipid peroxidation .","volume":"000","author":"Yang","year":"1996","journal-title":"J. Guangxi Med. Univ."},{"issue":"8","key":"10.1016\/j.biopha.2023.114522_bib88","first-page":"666","article-title":"Anisodamine inhibits acetylcholine-induced endothelium-dependent relaxation of canine femoral artery .","volume":"105","author":"Guo","year":"1992","journal-title":"Chin. Med. J."},{"issue":"2","key":"10.1016\/j.biopha.2023.114522_bib89","first-page":"190","article-title":"Blocking effect of anisodamine on acetylcholine receptor channels .","volume":"14","author":"Zhao","year":"1993","journal-title":"Zhongguo yao li xue bao= Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.biopha.2023.114522_bib90","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/CCM.0b013e31819598f5","article-title":"Antishock effect of anisodamine involves a novel pathway for activating \u03b17 nicotinic acetylcholine receptor .","volume":"37","author":"Liu","year":"2009","journal-title":"Crit. Care Med."},{"issue":"10","key":"10.1016\/j.biopha.2023.114522_bib91","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.1982.03320350062033","article-title":"Anisodamine inhibits thromboxane synthesis, granulocyte aggregation, and platelet aggregation: a possible mechanism for its efficacy in bacteremic shock .","volume":"247","author":"Rui-Juan","year":"1982","journal-title":"Jama"},{"issue":"12","key":"10.1016\/j.biopha.2023.114522_bib92","first-page":"871","article-title":"Effects of anisodamine on cardiovascular activities in endotoxin-shocked dogs .","volume":"97","author":"Yao","year":"1984","journal-title":"Chin. Med. J."},{"issue":"6","key":"10.1016\/j.biopha.2023.114522_bib93","first-page":"592","article-title":"A therapeutic effect of anisodamine combined with azithromycin sequential administration on children with mycoplasma pneumonia .","volume":"19","author":"Kang","year":"2017","journal-title":"J. Clin. Transfus. Lab. Med."},{"issue":"2","key":"10.1016\/j.biopha.2023.114522_bib94","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/cns.12213","article-title":"Combined treatment with anisodamine and neostigmine inhibits joint inflammation in collagen\u2010induced arthritis mice .","volume":"20","author":"Zhou","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.biopha.2023.114522_bib95","first-page":"2902","article-title":"Effect evaluation of 2% anisodamine cream in preventing chemotherapy phlebitis caused by 5-fluorouracil .","author":"Liu","year":"2017","journal-title":"Chongqing Med."},{"issue":"02","key":"10.1016\/j.biopha.2023.114522_bib96","first-page":"300","article-title":"Effects of anisodamine on the expressions of vascular endothelial growth factor and intercellular adhesion molecule 1 in experimental infusion phlebitis .","volume":"125","author":"Zhang","year":"2012","journal-title":"Chin. Med. J."},{"issue":"2","key":"10.1016\/j.biopha.2023.114522_bib97","article-title":"Effects of anisodamine on the expressions of tumor necrosis factor-\u03b1and cycloxygenase 2 in experimental infusion phlebitis .","volume":"9","author":"Zhenxiang","year":"2012","journal-title":"Life Sci. J."},{"issue":"2","key":"10.1016\/j.biopha.2023.114522_bib98","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.intimp.2010.12.001","article-title":"Modulatory effect of anisodamine on airway hyper-reactivity and eosinophilic inflammation in a murine model of allergic asthma .","volume":"11","author":"Xu","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2023.114522_bib99","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bbrc.2022.05.024","article-title":"Anisodamine potently inhibits SARS-CoV-2 infection in vitro and targets its main protease .","volume":"616","author":"Wei","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2023.114522_bib100","first-page":"2020","article-title":"Network pharmacology integrated molecular docking reveals the mechanism of anisodamine hydrobromide injection against novel coronavirus pneumonia .","author":"Su","year":"2020","journal-title":"Evid. -Based Complement. Altern. Med."},{"key":"10.1016\/j.biopha.2023.114522_bib101","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.fsi.2022.08.072","article-title":"Chitosan and anisodamine enhance the immersion immune efficacy of inactivated Elizabethkingia miricola vaccine in black spotted frogs .","volume":"130","author":"Qiao","year":"2022","journal-title":"Fish. Shellfish Immunol."},{"key":"10.1016\/j.biopha.2023.114522_bib102","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.fsi.2019.03.040","article-title":"Chitosan and anisodamine improve the immune efficacy of inactivated infectious spleen and kidney necrosis virus vaccine in Siniperca chuatsi .","volume":"89","author":"Zhang","year":"2019","journal-title":"Fish. Shellfish Immunol."},{"key":"10.1016\/j.biopha.2023.114522_bib103","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.fsi.2020.01.025","article-title":"\u03b2-glucan and anisodamine can enhance the immersion immune efficacy of inactivated cyprinid herpesvirus 2 vaccine in Carassius auratus gibelio .","volume":"98","author":"Yan","year":"2020","journal-title":"Fish. Shellfish Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2023.114522_bib104","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000080102","article-title":"Comparison of the inhibitory efficacy of four belladonna drugs on gastrointestinal movement and cognitive function in food-deprived mice .","volume":"72","author":"Pan","year":"2004","journal-title":"Pharmacology"},{"key":"10.1016\/j.biopha.2023.114522_bib105","series-title":"Multi-Center Phase III Trial in Chinese Patients; proceedings of the Gastroenterology, F","article-title":"Comparison of Efficacy and Safety of Hyoscine Butylbromide Versus Anisodamine for Acute Gastric or Intestinal Spasm-Like Pain: Results From a Randomized, Double-Blind, Parallel-Group","author":"Zhu","year":"2016"},{"key":"10.1016\/j.biopha.2023.114522_bib106","first-page":"579","article-title":"Application of anisodamine in modified air repair of intussusception in children .","author":"Zhang","year":"2018","journal-title":"J. Pract. Radiol."},{"key":"10.1016\/j.biopha.2023.114522_bib107","first-page":"3196","article-title":"Clinical research on trimebutine maleate, oryzanol and anisodamine combined application in treatment of the elderly patients with irritable bowel syndrome .","author":"Zhang","year":"2011","journal-title":"Chin. J. Prim. Med. Pharm."},{"key":"10.1016\/j.biopha.2023.114522_bib108","first-page":"2194","article-title":"The application of naloxone and anisodamine in the therapy of acute alcoholism .","author":"Zheng","year":"2010","journal-title":"Chin. J. Prim. Med. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2023.114522_bib109","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.etap.2013.12.016","article-title":"Efficiency of anisodamine for organophosphorus-poisoned patients when atropinization cannot be achieved with high doses of atropine .","volume":"37","author":"Wang","year":"2014","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.biopha.2023.114522_bib110","first-page":"1503","article-title":"Effect of anisodamine combined with blood purification on pulmonary fibrosis, serum matrix metalloproteinase-9 and matrix metalloproteinase 1 levels in patients with paraquat poisoning .","author":"Zhang","year":"2019","journal-title":"J. Chin. Physician"},{"issue":"1","key":"10.1016\/j.biopha.2023.114522_bib111","first-page":"25","article-title":"Anti-tumor effects of ephedrine and Anisodamine on Skbr3 human breast Cancer cell line .. African Journal of Traditional","volume":"13","author":"Chen","year":"2016","journal-title":"Complement. Altern. Med."},{"issue":"6","key":"10.1016\/j.biopha.2023.114522_bib112","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1177\/153537020122600614","article-title":"Anisodamine inhibits Shiga toxin type 2-mediated tumor necrosis factor-\u03b1 production in vitro and in vivo .","volume":"226","author":"Zhang","year":"2001","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.biopha.2023.114522_bib113","first-page":"30","article-title":"Clinical evaluation of compound betamethasone combined with anisodamine in treatment of eyebrow alopecia areata .","author":"Yang","year":"2011","journal-title":"Chin. J. Med. Aesthet. Cosmetol."},{"key":"10.1016\/j.biopha.2023.114522_bib114","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3389\/fphar.2019.01444","article-title":"Anisodamine ameliorates hyperkalemia during crush syndrome through estradiol-induced enhancement of insulin sensitivity .","volume":"10","author":"Yu","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.biopha.2023.114522_bib115","first-page":"2","article-title":"Analysis of the prognosis effect of anisodamine, Salvia miltiorrhiza combined with magnesium sulfate in the treatment of hypertensive disorders complicating pregnancy .","volume":"29","author":"Wu","year":"2017","journal-title":"Mod. Pract. Med."},{"key":"10.1016\/j.biopha.2023.114522_bib116","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.519172","article-title":"Anisodamine maintains the stability of intervertebral disc tissue by inhibiting the senescence of nucleus pulposus cells and degradation of extracellular matrix via interleukin-6\/Janus kinases\/signal transducer and activator of transcription 3 pathway .","volume":"11","author":"Tang","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2023.114522_bib117","first-page":"516","article-title":"Clinical research for treatment of diabetic peripheral neuropathy by combination. therapy with small doses of anisodamine injection and ligustrazine injection# br ..","volume":"40","author":"Ni","year":"2019","journal-title":"J. Hebei Med. Univ."},{"key":"10.1016\/j.biopha.2023.114522_bib118","first-page":"1080","article-title":"Clinical effect of anisodamine combined with gabapentin on painful diabetic neuropathy .","author":"Yu","year":"2019","journal-title":"Chin. J. Prim. Med. Pharm."},{"key":"10.1016\/j.biopha.2023.114522_bib119","first-page":"2068","article-title":"Effects of Anisodamine Combined with Oxytocin on Labor Process of Lying-in Women with Prolonged Active Phase in the First Labor Process and Related Indicators of Newborn .","author":"Li","year":"2016","journal-title":"China Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2023.114522_bib120","first-page":"202","article-title":"Experimental study on the protective effect of anisodamine on flaps with ischemia reperfusion injury .","volume":"29","author":"Lu","year":"2013","journal-title":"Zhonghua Zheng Xing wai ke za zhi= Zhonghua Zhengxing Waike Zazhi= Chin. J. Plast. Surg."},{"issue":"1","key":"10.1016\/j.biopha.2023.114522_bib121","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/10799893.2020.1713808","article-title":"Anisodamine alleviates lipopolysaccharide-induced pancreatic acinar cell injury through NLRP3 inflammasome and NF-\u03baB signaling pathway .","volume":"40","author":"Li","year":"2020","journal-title":"J. Recept. Signal Transduct."},{"key":"10.1016\/j.biopha.2023.114522_bib122","first-page":"187","article-title":"The study of treating acute pancreatitis with large dose of anisodamine combined with ulinastain .","author":"Zhang","year":"2014","journal-title":"Chin. J. Emerg. Med."},{"issue":"10","key":"10.1016\/j.biopha.2023.114522_bib123","first-page":"763","article-title":"Determination of serum concentration and pharmacokinetic parameters of anisodamine by micellar liquid chromatography .","volume":"27","author":"Ma","year":"1992","journal-title":"Chin. J. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2023.114522_bib124","first-page":"114","article-title":"Determination of anisodamine concentration and pharmacokinetic parameters by reverse phase HPLC .","volume":"21","author":"He","year":"1998","journal-title":"J. Xinjiang Med. Coll."},{"issue":"19","key":"10.1016\/j.biopha.2023.114522_bib125","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1002\/jssc.201300451","article-title":"Development and validation of a rapid and sensitive assay for the determination of anisodamine in 50 \u03bc L of beagle dog plasma by LC\u2013MS\/MS .","volume":"36","author":"Li","year":"2013","journal-title":"J. Sep. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2023.114522_bib126","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s13318-014-0192-y","article-title":"Comparative study on pharmacokinetics of a series of anticholinergics, atropine, anisodamine, anisodine, scopolamine and tiotropium in rats .","volume":"40","author":"Tian","year":"2015","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.biopha.2023.114522_bib127","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1570-0232(04)00510-0","article-title":"Study of stereoselective pharmacokinetics of anisodamine enantiomers in rabbits by capillary electrophoresis .","volume":"809","author":"Fan","year":"2004","journal-title":"J. Chromatogr. B"},{"issue":"8","key":"10.1016\/j.biopha.2023.114522_bib128","first-page":"5","article-title":"Effect of Xuebijing combined with anisodamine on inflammatory factors, immune function and coagulation function in patients with multiple trauma complicated with hemorrhagic shock .","volume":"34","author":"Lv","year":"2022","journal-title":"West. Med."},{"issue":"7","key":"10.1016\/j.biopha.2023.114522_bib129","first-page":"4","article-title":"Effects of anisodamine hydrobromide on microcirculation and coronary endothelial function in patients with cardiac arrest undergoing cardiopulmonary resuscitation .","volume":"17","author":"Lv","year":"2022","journal-title":"Chin. J. Emerg. Resusc. Disaster Med."},{"key":"10.1016\/j.biopha.2023.114522_bib130","first-page":"020","article-title":"Effect of anisodamine postauricular subcutaneous injection combined with ginkgo dipyridamole in the treatment of otogenic vertigo .","volume":"013","author":"Tan","year":"2022","journal-title":"J. Contemp. Med."},{"issue":"3","key":"10.1016\/j.biopha.2023.114522_bib131","first-page":"5","article-title":"Clinical study of anisodamine combined with montelukast in the treatment of children with Henoch-Schonlein purpura and analysis of risk factors for recurrence .","volume":"37","author":"Zhu","year":"2021","journal-title":"Chin. J. Pract. Med"},{"issue":"6","key":"10.1016\/j.biopha.2023.114522_bib132","first-page":"1","article-title":"Comparison of the efficacy of ambroxol hydrochloride and N\u2011acetylcysteine in the treatment of children with bronchopneumonia and their influence on prognosis .","volume":"20","author":"Liu","year":"2020","journal-title":"Exp. Ther. Med."},{"issue":"23","key":"10.1016\/j.biopha.2023.114522_bib133","first-page":"2","article-title":"Clinical efficacy and pharmacological analysis of anisodamine combined with terbutaline in the treatment of children with bronchopneumonia .","volume":"19","author":"Qin","year":"2021","journal-title":"Chin. Med. Guide"},{"key":"10.1016\/j.biopha.2023.114522_bib134","unstructured":"National Essential Medicines List [M]. National Health Commission of China, 2012."},{"issue":"4","key":"10.1016\/j.biopha.2023.114522_bib135","first-page":"3","article-title":"Evaluation of clinical application of anisodamine drugs .","volume":"2","author":"Yu","year":"2002","journal-title":"Drug Eval. Anal. Chin. Hosp."},{"key":"10.1016\/j.biopha.2023.114522_bib136","author":"Carlson","year":"2018","journal-title":"Physiol., Cholinergic Recept. [J]"},{"issue":"6","key":"10.1016\/j.biopha.2023.114522_bib137","first-page":"800","article-title":"Research progress on the pharmacology and clinical application of anisodamine .","volume":"6","author":"Jin","year":"2012","journal-title":"Med. Seek. Med. ( Second Half Mon. )"},{"issue":"2","key":"10.1016\/j.biopha.2023.114522_bib138","first-page":"137","article-title":"New drugs derived from medicinal plants .","volume":"57","author":"Zhang","year":"2002","journal-title":"Therapie"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223003104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223003104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T16:30:32Z","timestamp":1781281832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223003104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":138,"alternative-id":["S0753332223003104"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114522","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on the sources, pharmacokinetics, pharmacological action, and clinical application of anisodamine","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114522","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114522"}}